Immunotherapy News and Research

Latest Immunotherapy News and Research

PD-1 protein could serve as biomarker for predicting survival of lung cancer patients

PD-1 protein could serve as biomarker for predicting survival of lung cancer patients

Experimental T-cell therapy shows promise in preventing AML relapse

Experimental T-cell therapy shows promise in preventing AML relapse

Dual therapy safe and effective in patients with recurrent Hodgkin lymphoma

Dual therapy safe and effective in patients with recurrent Hodgkin lymphoma

New FDA-approved drug helps patients fight against late-stage lung cancer

New FDA-approved drug helps patients fight against late-stage lung cancer

UC San Diego scientists reveal surprising role for Hippo pathway in subduing tumor immunogenicity

UC San Diego scientists reveal surprising role for Hippo pathway in subduing tumor immunogenicity

New device could revolutionize drug delivery to treat cancer and other diseases, study shows

New device could revolutionize drug delivery to treat cancer and other diseases, study shows

Novel imaging technique shows promise to detect, monitor and guide therapy for prostate cancer

Novel imaging technique shows promise to detect, monitor and guide therapy for prostate cancer

TGen and City of Hope collaborate to accelerate precision medicine research

TGen and City of Hope collaborate to accelerate precision medicine research

MGH researchers develop new methods for mapping and measuring solid stress in tumors

MGH researchers develop new methods for mapping and measuring solid stress in tumors

CNIC study characterizes key signal that impedes intercellular communication

CNIC study characterizes key signal that impedes intercellular communication

Clinically-proven pharmacy product effective against causes of Traveller's Diarrhoea

Clinically-proven pharmacy product effective against causes of Traveller's Diarrhoea

ADVANCECAT enables development of advanced therapies to benefit Catalan health system

ADVANCECAT enables development of advanced therapies to benefit Catalan health system

Leading nonprofit patient education organization offers allergy-related restaurant safety tips

Leading nonprofit patient education organization offers allergy-related restaurant safety tips

Study shows new drug combination effective in treating precancerous skin lesions

Study shows new drug combination effective in treating precancerous skin lesions

Researchers focus on optimal use of immune agents in frontline setting for NSCLC treatment

Researchers focus on optimal use of immune agents in frontline setting for NSCLC treatment

ACAAI offers tips for bringing holiday flair, not allergic flares

ACAAI offers tips for bringing holiday flair, not allergic flares

Veterans Affairs researchers discover alleles of certain genes that offer protection from GWI

Veterans Affairs researchers discover alleles of certain genes that offer protection from GWI

HC-based NGS helps detect genomic alterations not identified in routine lung cancer screening

HC-based NGS helps detect genomic alterations not identified in routine lung cancer screening

T cell channel could be potential new target for treating head and neck cancers

T cell channel could be potential new target for treating head and neck cancers

Enterome, Bristol-Myers Squibb enter into Immuno-Oncology collaboration to identify new microbiome-derived biomarkers for cancer

Enterome, Bristol-Myers Squibb enter into Immuno-Oncology collaboration to identify new microbiome-derived biomarkers for cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.